Organization
Charité University Hospital
4 abstracts
Abstract
Patient-reported outcomes (PROs) from a randomized, phase 3 trial of enfortumab vedotin plus pembrolizumab (EV+P) versus platinum-based chemotherapy (PBC) in previously untreated locally advanced or metastatic urothelial cancer (la/mUC).Org: Taussig Cancer Institute, Cleveland Clinic Lerner College of Medicine, Université Paris-Sud, Université Paris-Saclay, Netherlands Cancer Institute,
Abstract
Rapid establishment of patient-derived organoids from treatment-naive head and neck cancer patients for drug and radiosensitivity screening.Org: Charité University Hospital, Charite University Hospital Berlin, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin,
Abstract
ANGIOTENSIN AND ENDOTHELIN RECEPTOR EXPRESSION IN PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS) FROM HEALTHY DONORS AND SYSTEMIC SCLEROSIS (SSC) PATIENTS Org: German Rheumatism Research Centre, Pathophysiology of Rheumatic Inflammation, Berlin, Germany, Charité University Hospital,
Abstract
ADALIMUMAB IS EFFECTIVE AND WELL-TOLERATED IN TREATING ANKYLOSING SPONDYLITIS (AS) IN REAL-LIFE CLINICAL PRACTICE: PRELIMINARY RESULTS OF THE RHAPSODY TRIALOrg: Rheumatology, Society of Patients with Rheumatism, Cracow, Poland, Charité University Hospital, Berlin Heals, Germany, CHU de Henri-Mondor,